3D Pharmacophore models are three-dimensional ensembles of chemically specified interactions of a ligand in its bioactive state. They are now an important technique in drug design because they offer a sophisticated method of deciphering chemically stored ligand information. The important research for using 3D pharmacophore models in high - throughput screening and mechanistic investigations for protein functioning are summarised in this review, along with an outline of the method's fundamental principles. We also go over current advancements in the area. Since these methods take into account macromolecule-ligand interactions as dynamic and hence display an interaction pattern that is physiologically accurate, combining 3D pharmacophore models with molecular dynamics simulations might be a huge step forward. The effective use of 3D pharmacophore data in artificial intelligence and machine learning is another trend. Other themes include using 3D pharmacophore data effectively in machine learning and artificial intelligence applications or providing 3D pharmacophore modelling on publicly available web servers. Recent advancements demonstrate that 3D pharmacophore modelling is a dynamic area with many implications in drug discovery and beyond.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia